2019-2024 Ophthalmology Drug and Device Market Comprehensive Outlook by Leading Players, Development Status, Source of Power, Estimated CAGR, and Forecast

Ophthalmology Drug and Device

The primary goal of this Global Ophthalmology Drug and Device Market report is to maintain the record of Unusual growth strategies adopted by various companies are creating new standards for competition in the global Ophthalmology Drug and Device market. Businesses around the world are aiming at increasing their profit margin and establishing a stronghold in the global market. The impact of prevailing regulatory scenario on both regional and worldwide Ophthalmology Drug and Device market is provided in detail in the report.

Get Sample Copy of Ophthalmology Drug and Device Market Report @ https://www.industryresearch.co/enquiry/request-sample/14099190

Key Market Trends:

Cataract Surgery Devices are Expected to Hold a Significant Market Share in the Surgical Device Type

According to the Royal College of Ophthalmologists, the United Kingdom, around 330,000 cataract operations are performed each year in England alone. It has been estimated that 30% of people aged 65 years or more have a visually impairing cataract in one or both eyes. Some populations tend to have a much higher prevalence of cataracts. For instance, 77% of the British people, aged 42 years or older, originating from the Indian subcontinent have cataracts. There is a threefold variation in the number of people having cataract surgery across England, owing to differences in health commissioning policies.
Similarly, as stated by the American Academy of Ophthalmology, approximately 24.5 million people in the United States have cataracts, which is the leading cause of blindness in the United States. Cataract surgery remains the most effective way to help restore vision for these people with cataracts.

North America Dominates the Market and Expected to do the Same during the Forecast Period

Due to the presence of well-established healthcare facilities, the rise in geriatric population in the region, and certain other factors, North America dominates the ophthalmology drug and device market. Owing to the constant increase in the American elderly population, as well as a movement toward vision correction and its usage among key demographics, an absolute increase in usage rates for most types of eyewear was observed in the United States. Additionally, the government of Canada states that the average revenue of the small and medium-sized enterprises, primarily engaged in retailing and fitting prescription eyeglasses, was found to be USD 565.2 thousand, in 2016, whereas the profit was around 77-78%.

Ophthalmology Drug and Device Market Covers Key Players:

  • Alcon Inc.
  • Bausch & Lomb Inc.
  • Carl Zeiss Meditec AG
  • Essilor International SA
  • Haag
  • Streit Group
  • Johnson & Johnson
  • Nidek Co. Ltd
  • Topcon Corporation
  • Ziemer Ophthalmic Systems AG

    Ask for Discount at https://www.industryresearch.co/enquiry/request-discount/14099190

    Geographical Landscape:

    This Report Focuses on the Ophthalmology Drug and Device in the Global market, especially in North America, China, Europe, Japan, Southeast Asia, India. This report categorizes the market based on manufacturers, regions, type, and application

    Market Overview:

  • The ophthalmology drug and device market is expected to witness a CAGR of 5.3% during the forecast period. Certain factors that are driving the growth of the market include demographic shift, impact of the prevalence of eye disease, technological advancements in the field of ophthalmology, and rising geriatric population.
  • Cataract volume registered a rapid increase in recent years. The aging population is expected to burden all areas of health care, and ophthalmologists provide approximately 90% of their procedure-based services to seniors. In many countries, cataract surgery is the most frequent surgical procedure performed, and it offers significant improvements in the quality of life of the elderly population at low costs. An increase in the demand for ophthalmological devices projects the future cataract surgery needs that are vital for human health resources and hospitals, and for surgical center management and planning.
  • Other factors, such as the availability of new drugs and devices and the prevalence of eye disease, are also expected to drive the market over the forecast period.
  • Many regulations are imposed by agencies, such as the FDA, to ensure the safety and efficacy of products. Due to frequent occurrences of violations, tighter regulations were enforced on the label contents. The cost of complying with FDA guidelines is expected to drive many small pharmacies out of business or force them to consolidate. For example, these regulations impose a beyond-use date of only five days for bevacizumab and other biologics. However, it takes 14 days just to test the sterility of these drugs, which means that the regulations for compounded ophthalmology drugs besides bevacizumab, such as ophthalmology mitomycin, and triamcinolone acetonide plus moxifloxacin hydrochloride injection, will become much more expensive or even unavailable.
  • Additionally, increasing healthcare cost and economic slowdown in developed countries are also restraining the market’s growth.

    Report Highlights:

    – The report provides a detailed analysis on current and future market trends to identify the investment opportunities

    – Market forecasts till 2024, using estimated market values as the base numbers

    – Key market trends across the business segments, Regions and Countries

    – Key developments and strategies observed in the market

    – Market Dynamics such as Drivers, Restraints, Opportunities and other trends

    – In-depth company profiles of key players and upcoming prominent players

    – Growth prospects among the emerging nations through 2024

    – Ophthalmology Drug and Device Market opportunities and recommendations for new investments

    Price Of Report: $ 4250 (SUL)

    Purchase Ophthalmology Drug and Device Market Report @ https://www.industryresearch.co/purchase/14099190

    Detailed TOC of Ophthalmology Drug and Device Market Research Report 2019 – 2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Demographic Shift and Impact of Prevalence of Eye Disease
    4.2.2 Technological Advancements in the Field of Ophthalmology
    4.2.3 Rising Geriatric Population
    4.3 Market Restraints
    4.3.1 Increasing Healthcare Costs
    4.3.2 Economic Slowdown in Developed Markets
    4.3.3 Strict FDA Guidelines for Drug Approval
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 Device
    5.1.1 Surgical Device Glaucoma Surgery Devices Cataract Surgery Devices Refractive Surgery Devices Vitreoretinal Surgery Devices Other Surgical Devices
    5.1.2 Diagnostic and Monitoring Device Fundus Cameras Ophthalmoscopes Retinoscopes Keratometers Wavefront Aberrometers Tonometers Ophthalmic Ultrasound Imaging Systems Optical Coherence Tomography Scanners Visual Field Analyzers Slit Lamps Other Diagnostic and Monitoring Devices
    5.1.3 Vision Care Spectacles Contact Lens
    5.2 Drug
    5.2.1 Glaucoma Drugs
    5.2.2 Retinal Disorder Drugs
    5.2.3 Dry Eye Drugs
    5.2.4 Allergic Conjunctivitis and Inflammation Drugs
    5.2.5 Other Drugs
    5.3 Geography
    5.3.1 North America US Canada Mexico
    5.3.2 Europe Germany UK France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Alcon Inc.
    6.1.2 Bausch & Lomb Inc.
    6.1.3 Carl Zeiss Meditec AG
    6.1.4 Essilor International SA
    6.1.5 Haag-Streit Group
    6.1.6 Johnson & Johnson
    6.1.7 Nidek Co. Ltd
    6.1.8 Topcon Corporation
    6.1.9 Ziemer Ophthalmic Systems AG


    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Industry Research

    Phone: +44 20 3239 8187 / +14242530807

    Email: [email protected]

    Our latest Report: Lecithin Market Segmentation 2019-2023 Covers Price, Sales, Revenue, Growth Rate Details by Regions, Types, and Applications